PHARMASEAL

PHARMASEAL is a life sciences technology company dedicated to transforming the management and execution of clinical trials. Their flagship platform, Engility®, is a cloud-based, unified Clinical Trial Management System (CTMS) and electronic Trial Master File (eTMF) solution designed to help companies reduce risk, optimise costs, and improve decision-making through integrated business processes and real-time intelligence.

Engility® is an adaptive, flexible platform built for companies of all sizes — from those running single trials to organisations managing high volumes — with no user-based pricing. It has been carefully engineered by clinical technology experts to serve a broad range of life sciences organisations, and is supported by a leadership team with deep industry expertise spanning PAREXEL, Amgen, Roche, Medidata, and Pfizer.

Engility® Platform — Key Capabilities

• Unified CTMS + eTMF: A single system combining trial management and document management, eliminating the need for separate platforms and providing one centralised source of data.
• Supply Chain Collaboration: The platform can be shared between sponsors and suppliers, enabling greater efficiency, transparency, better decision-making, and reduced risk across the clinical supply chain.
• Rapid Implementation and Configuration: Engility® can be implemented within weeks rather than months, significantly accelerating time-to-value for new customers.
• Standardised EDC Integration: Includes out-of-the-box integration with Electronic Data Capture (EDC) systems, further reducing costs and shortening trial timelines.
• Real-Time Intelligence: Provides real-time data and insights to support smarter management and oversight of clinical trials.
• Flexible Configuration: The platform can be configured to meet the varying requirements of different sponsors and trial types.

Who Engility® Serves

• Biopharma Companies: Maintain complete trial oversight for both internal and outsourced clinical trials.
• Medical Device Companies: Provides oversight and control of Medical Device Regulation (MDR) initiatives.
• Animal Health Organisations: Supports oversight for internal and outsourced animal health clinical trials.
• Contract Research Organisations (CROs): Offers flexible configuration to accommodate different sponsor requirements.
• Academic Institutions: Delivers affordable enterprise technology that reduces total cost of ownership.
• Nutraceuticals and Cosmetics Companies: Links people, processes, and information through a single source of centralised data.

Deployment and Technology

• Fully cloud-based platform accessible to organisations of all sizes.
• Volume-based pricing model with no per-user fees, making it scalable and cost-effective.
• Designed for rapid deployment, with implementation timelines measured in weeks.
• Built to support both internal teams and outsourced clinical operations through collaborative, shared access.

Leadership and Advisory Team

• Daljit Cheema, Founder & CEO: Brings 30 years of life sciences technology leadership, including senior roles at PAREXEL International and as CTO of Clinphone, which achieved an LSE IPO in 2006 before being acquired by PAREXEL in 2008. Founded PHARMASEAL in 2016.
• Ricky Lakhani, Chief Product Officer: Over 17 years of experience in life sciences and technology, with prior roles at Amgen, Roche, and Medidata, focused on product innovation for clinical trial execution.
• Hugh O'Neill, VP Quality and Operations: PhD Scientist with over 30 years of pharmaceutical industry experience, including 25 years in IT roles and 10 years in quality management. Secretary of the RQA IT Committee.
• John Young, Advisor: Former Group President and Senior Advisor to the Pfizer CEO with over 35 years of pharmaceutical industry experience. Currently serves on the boards of Novartis, Johnson Controls International, and Arvinas.
• Wayne R. Kubick, Advisor: Over 30 years of experience in clinical research technology; former CTO of Health Level Seven International (HL7), where he led development of the FHIR standard. Previously held senior roles at CDISC, PAREXEL, and Oracle Health Sciences.
• Karen Roy, Advisor: Co-developer of the CDISC TMF Reference Model, the industry-standard framework for Trial Master File content and structure. Currently working with CDISC on transitioning the model to a formal CDISC Standard, and a board member of the Institute of Clinical Research.

PHARMASEAL's mission is to build innovative technology that transforms clinical trial processes, empowers teams, and puts the power of information and decision-making directly in the hands of clinical organisations — ultimately contributing to the faster delivery of life-saving therapies to patients worldwide.